I've seen BSI give the following guidance:
All submissions should be accompanied by a market history to enable an understanding of the context of device development.
• If the device is new and has never been marketed by the manufacturer anywhere in the world, please state this explicitly.
• For existing devices:
- Ensure that a market history is provided indicating the nature and timing of any changes and that any associated documents (i.e. risk analyses, labelling, clinical evaluation reports, verification / validation data, etc.) account for these changes.
- Provide evidence (e.g., BSI Reference numbers of previous reviews) to demonstrate that BSI has been notified of all significant changes (if applicable).
- For initial applications under MDR, please confirm whether the device has been previously marketed under MDD and whether any changes have been made in comparison to the MDD-certified device
- Market history should include EU and approvals in other geographies.
------------------------------
Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
Principal Consultant
Ridgway, CO
United States
© Copyright 2022 by ComplianceAcuity, Inc. All rights reserved.
------------------------------
Original Message:
Sent: 25-Jan-2022 12:27
From: Ed Panek
Subject: MDR Definition
In the phrase "Previous generations of the device" what is meant by "generations?" When does one generation end and a new one begin? Are they able to exist at the same time?
------------------------------
Edward Panek
VP, QA/RA
Med Device
USN Veteran
Research into Neural Nets - https://www.twitch.tv/edosani
------------------------------